Werewolf Therapeutics

Werewolf Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative cancer treatments that harness the body's immune system. They specialize in conditionally activated therapies, which are designed to be inactive in healthy tissues but selectively activate within the tumor microenvironment, maximizing therapeutic potential while minimizing side effects. Their proprietary PREDATOR™ platform allows them to engineer these unique INDUKINE™ molecules, which are designed to stimulate both adaptive and innate immunity.

Werewolf is currently advancing two leading product candidates, WTX-124 and WTX-330, both of which are systemically delivered and conditionally activated. WTX-124 is an Interleukin-2 (IL-2) INDUKINE molecule being developed for multiple solid tumor types, both as a monotherapy and in combination with pembrolizumab. WTX-330, a conditionally activated Interleukin-12 (IL-12) INDUKINE molecule, is being developed for the treatment of advanced or metastatic solid tumors and Non-Hodgkin Lymphoma. Werewolf's mission is to redefine the cancer treatment landscape with their next-generation, transformative immunotherapies.

Werewolf Therapeutics is an immuno-oncology company dedicated to developing innovative cancer treatments that leverage the body's immune system. They focus on creating next-generation therapies that target and harness the immune response to combat cancer, ultimately improving patient outcomes and quality of life. Their mission is driven by the desire to redefine the cancer treatment landscape with potential best-in-class therapies.

Werewolf Therapeutics promotes a vibrant and innovative culture, seeking creative and forward-thinking individuals who are passionate about making a difference in the fight against cancer. They value a collaborative environment where experienced physician-scientists and industry veterans work together to develop groundbreaking therapies. Their commitment to improving patient outcomes and quality of life drives their work, creating a fast-paced and rewarding environment for those who are driven to make a real impact.